Physician profile
Dipayon Roy
NPI 1720434541
$13,983.75
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2021: $110 · 2022: $188 · 2023: $10K · 2024: $2,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,750 · Food and Beverage: $2,920 · Travel and Lodging: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,750.00 |
| Food and Beverage | $2,920.11 |
| Travel and Lodging | $1,651.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,317.08 | 2021-2024 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $1,614.51 | 2022-2024 | Ensite Precision, Ensite, Aveir |
| Medtronic Vascular, INC. | $364.44 | 2019 | |
| Biosense Webster, INC. | $277.74 | 2024 | Carto 3, Soundstar, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $277.06 | 2021-2023 | Lifevest |
| Biotronik INC. | $97.96 | 2023 | |
| Philips North America LLC | $34.96 | 2023 | (9520) Igt Devices Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipayon Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.